We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Boots Group put its non-prescription medicines unit up for sale to focus on
reviving its UK drugstore chain and said profit may drop for a second year.
A federal court in Australia upheld Dusa Pharmaceutical's patent for a dermatological
treatment, but the court also said PhotoCure's competing product, Metvix does
not infringe on its Australian patent claims.
Action by Nigerian food and drug regulator NAFDAC to curtail the
country's rampant counterfeit drug industry has attracted harsh criticism, amid
claims that the moves will halt sales of therapeutically effective generic drugs.
A recent industry conference in Paris has highlighted the decline
of the French R&D sector, with drugmakers and hospitals pledging to "mobilise"
efforts to coordinate public-private research partnerships and boost clinical
trials.
Serono SA Wednesday said it is terminating trials on two drugs in late development
that the Swiss biopharmaceutical company had hoped would reduce its dependence
on just one product for growth.
Investment in pharmaceuticals research in Britain has dipped for the first time
as the country faces growing competition from the United States, China, India,
Singapore and eastern Europe, the industry said on Tuesday.